Clinical Trial Update: Efficacy and Safety of LH-8 in Paediatric Alopecia Areata [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial results report on the efficacy and safety of LH-8 for pediatric alopecia areata, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alopecia Areata

Drugs mentioned

• LH-8

Snippet

Sponsor: Legacy Healthcare SA | Conditions: Alopecia Areata, Pediatric Disorder | Phase 2, Phase 3 | Status: COMPLETED